ID: 6807 | Pages: 145 | March 2018 | Region: Europe
The Europe Non-Vascular Stents market size was around USD 257.6 million in 2017. It is expected to grow at a CAGR of 5.3% to reach USD 333.49 million by 2022. It captures 28% of the global market.
Stents are the tubes or other devices that placed in the body to generate a passage between hollow spaces. And stenting is process of placement of such stent in the body. Non-vascular stents are usually utilized for making a pathway in vessels of the body particularly the arteries and veins that carry lymph and blood.
Rapid technological advancements in the healthcare sector, increasing disease prevalence of cancer and urolithiasis, augmenting geriatric population and increased life expectancy are the primary drivers of market growth.
However, stringent administrative framework, unreliable efficiency, pricing pressures, and medical devices excise taxes are the primary restraints of this market.
The market is segmented by type, end user and by material. By type it is segregated into Pancreatic and Biliary Stents, Gastrointestinal Stents, Airway Stents, and Urinary Tract Stents. Biliary Stents is further sub-segmented into Plastic Biliary Stents and Metal Biliary Stents. Metal Biliary Stents is further sub-categorized into Metal Non-Covered Biliary Stents, Metal Partially Covered Biliary Stents, and Metal Fully Covered Biliary Stents. Pancreatic Stents are further sub-categorized into Plastic Pancreatic Stents and Metal Pancreatic Stents. Metal Pancreatic Stents are classified into Metal Non-Covered Pancreatic Stents and Metal Fully Covered Pancreatic Stents. Gastrointestinal Stents are segmented into Fully Covered Gastrointestinal Stents, Partially Covered Gastrointestinal Stents, and Non-Covered Gastrointestinal Stents. Airway Stents are classified into Silicone Airway Stents and Metallic Airway Stents. Metallic Airway Stents are segmented into Fully Covered Metallic Airway Stents and Uncovered Metallic Airway Stents. Urinary Tract Stents are categorized into Ureteral Stents, Metal Ureteral Stents, Polymer Ureteral Stents, Bioabsorbable Ureteral Stents, Prostate Stents, Metal Prostrate Stents, Polymer Prostrate Stents, Bioabsorbable Prostate Stents, Urethral Stents, Metal Urethral Stents, Polymer Urethral Stents, and Bioabsorbable Urethral Stents.
By geography the market is segmented into UK, Spain, Germany, France and others. Europe is also expected to hold a substantial market share during the forecast period due to the flourishing medical technology sector and increasing prevalence of gastric cancer in the EU5 countries.
Key players in the market include CONMED Corporation. Other players in the market include Taewoong Medical Co., Medtronic; C. R. Bard, Inc.; Boston Scientific Corporation; HOBBS MEDICAL, INC; Cook Medical; ELLA - CS, s.r.o.; Ltd.; Synchron Med Inc.; and Glaukos Corporation.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 End User
5.1.1 Introduction
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Others
5.1.5 Y-o-Y Growth Analysis, By End User
5.1.6 Market Attractiveness Analysis, By End User
5.1.7 Market Share Analysis, By End User
5.2 Type
5.2.1 Introduction
5.2.2 Pancreatic and Biliary Stents
5.2.2.1 Biliary Stents
5.2.2.1.1 Plastic Biliary Stents
5.2.2.1.2 Metal Biliary Stents
5.2.2.1.2.1 Metal Non-Covered Biliary Stents
5.2.2.1.2.2 Metal Partially Covered Biliary Stents
5.2.2.1.2.3 Metal Fully Covered Biliary Stents
5.2.2.2 Pancreatic Stents
5.2.2.2.1 Plastic Pancreatic Stents
5.2.2.2.2 Metal Pancreatic Stents
5.2.2.2.2.1 Metal Non-Covered Pancreatic Stents
5.2.2.2.2.2 Metal Fully Covered Pancreatic Stents
5.2.3 Gastrointestinal Stents
5.2.3.1 Fully Covered Gastrointestinal Stents
5.2.3.2 Partially Covered Gastrointestinal Stents
5.2.3.3 Non-Covered Gastrointestinal Stents
5.2.4 Airway Stents
5.2.4.1 Silicone Airway Stents
5.2.4.2 Metallic Airway Stents
5.2.4.2.1 Fully Covered Metallic Airway Stents
5.2.4.2.2 Uncovered Metallic Airway Stents
5.2.5 Urinary Tract Stents
5.2.5.1 Ureteral Stents
5.2.5.2 Metal Ureteral Stents
5.2.5.3 Polymer Ureteral Stents
5.2.5.4 Bioabsorbable Ureteral Stents.
5.2.5.5 Prostate Stents
5.2.5.6 Metal Prostrate Stents
5.2.5.7 Polymer Prostrate Stents
5.2.5.8 Bioabsorbable Prostate Stents.
5.2.5.9 Urethral Stents
5.2.5.10 Metal Urethral Stents
5.2.5.11 Polymer Urethral Stents
5.2.5.12 Bioabsorbable Urethral Stents
5.2.6 Y-o-Y Growth Analysis, By Type
5.2.7 Market Attractiveness Analysis, By Type
5.2.8 Market Share Analysis, By Type
5.3 Material
5.3.1 Introduction
5.3.2 Metallic Stents
5.3.3 Non-metallic Stents
5.3.4 Y-o-Y Growth Analysis, By Material
5.3.5 Market Attractiveness Analysis, By Material
5.3.6 Market Share Analysis, By Material
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By End User
6.1.3.3 By Type
6.1.3.4 By Material
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By End User
6.1.4.3 By Type
6.1.4.4 By Material
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By End User
6.1.5.3 By Type
6.1.5.4 By Material
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Boston Scientific Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Covidien plc. Cook Medical
8.3 Allium Medical Solutions Ltd.
8.4 Novatech Health Care
8.5 ConMed
8.6 W. L. Gore & Associates Inc.
8.7 C.R. Bard
8.8 Merit Endotek
8.9 Micro-Tech (Nanjing) Co., Ltd
8.10 ELLA - CS
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures  
Title | Price | Add To Cart |
© 2018 Market Data Forecast
All Rights Reserved.